(Q44051250)

29 November 2017

title

Epidermal growth factor receptor gene mutations in papillary thyroid carcinoma (English)

1 reference

29 November 2017

Katsuhiro Masago

1

1 reference

29 November 2017

Ryo Asato

2

1 reference

29 November 2017

Shiro Fujita

3

1 reference

29 November 2017

Shigeru Hirano

4

1 reference

29 November 2017

Yoshihiro Tamura

5

1 reference

29 November 2017

Tomoko Kanda

6

1 reference

29 November 2017

Tadashi Mio

7

1 reference

29 November 2017

Nobuyuki Katakami

8

1 reference

29 November 2017

Michiaki Mishima

9

1 reference

29 November 2017

Juichi Ito

10

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

International Journal of Cancer

29 November 2017

published in

1 reference

29 November 2017

volume

124

1 reference

29 November 2017

issue

11

1 reference

29 November 2017

page(s)

2744-2749

1 reference

29 November 2017

cites work

Cancer statistics, 2008

1 reference

Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.

21 January 2018

1 reference

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial

21 January 2018

1 reference

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp

21 January 2018

1 reference

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

21 January 2018

1 reference

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

Epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

EGFR antagonists in cancer treatment

21 January 2018

1 reference

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

Transcriptional control of lung morphogenesis

21 January 2018

1 reference

Development of the thyroid gland: lessons from congenitally hypothyroid mice and men.

21 January 2018

1 reference

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

21 January 2018

1 reference

Epidermal growth factor receptor status in anaplastic thyroid carcinoma

21 January 2018

1 reference

Cohort study of thyroid cancer in a San Francisco Bay area population

21 January 2018

1 reference

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

21 January 2018

1 reference

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

21 January 2018

1 reference

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

21 January 2018

1 reference

Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.24250

1 reference

29 November 2017

1 reference